OM1 Valuation, Funding & Investors

H1.co is a New York-based healthcare intelligence platform founded in 2017 that aggregates data on over 4 million healthcare professionals and 1,000 institutions. The service enables life sciences companies, hospitals, and health systems to access provider insights, clinical trial matching, and benchmarking tools. H1 connects stakeholders through its HCP Universe database and partners with entities like Pfizer and Mayo Clinic.

MedGenome is a Bangalore-based genomics company offering next-generation sequencing diagnostics and research services for cancer, metabolic, cardiac, and rare diseases. The firm operates CLIA-certified labs in the United States and India, processing samples for over 500 hospitals and research institutions. Its platform integrates bioinformatics with population-scale data from South Asian genomes, supporting drug discovery partnerships with AstraZeneca and Bristol Myers Squibb in precision medicine initiatives.

Sophia Genetics SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It has built a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The Company had a physical presence in three countries outside of its headquarters in Switzerland: France, the United States, and Brazil.

HealthVerity is a healthcare data technology company enabling providers, pharmaceutical manufacturers, hospitals, and payers to integrate patient data from diverse sources. Its identity resolution and matching tools support interoperable data exchange while maintaining privacy protections. Headquartered in Philadelphia, Pennsylvania, and founded in 2014, HealthVerity facilitates rapid dataset creation for analytics and insights across the healthcare sector.

Thrive Global is a behavior change technology company offering platforms, apps, and corporate programs for wellness. New York City-headquartered with offices in San Francisco, Athens, Bucharest, Dublin, and Melbourne, it launched in 2016 to promote science-based practices reducing burnout in workplaces.

DXY is an online platform connecting doctors, patients, and healthcare organizations in China via specialized social media for pharmaceuticals and life sciences. Hangzhou-headquartered since 2000, it provides communication tools, public health services, and precision marketing. Backed by Tencent, Hillhouse Capital, and Legend Capital, DXY enhances medical collaboration and productivity.

Evidation Health is a San Mateo-headquartered company founded in 2012 that measures health outcomes through everyday activities via its Achievement platform. The platform enables participation in research and health programs with partners in healthcare and pharmaceuticals. Evidation maintains offices worldwide and emphasizes user-controlled health data for studies beyond clinical settings.

Truveta is a data platform formed by 13 US health systems compiling de-identified records from 70 million patients. Launched in 2021, it enables researchers in pharma and academia to query real-world evidence linking treatments to outcomes across oncology, cardiology, and neurology. Partners include Providence, Banner Health, and Sanford Health, powering 500+ studies with query results in hours versus months.

SkyCell is a Zug, Switzerland-based provider of smart temperature-controlled containers for pharmaceutical logistics. The company equips units with real-time monitoring sensors compliant with GDP standards for vaccines and biologics. SkyCell serves Novartis, Pfizer, and Roche with reusable Reefers tracking temperature from -80°C to +25°C. Its Matrix platform prevents excursions through predictive alerts and serves routes across Europe and North America.

DNAnexus is a Mountain View-headquartered cloud platform for genomic data management and analysis. Founded in 2009, the company supports petabyte-scale storage, HIPAA-compliant collaboration, and AI workflows for clients including the Broad Institute, Illumina, and NHS Genomics England. DNAnexus operates data centers in the US, Europe, and Asia, powering projects like the UK Biobank analysis and COVID-19 surveillance. Its Apollo system enables secure multi-tenant research across 100,000 genomes.

iCarbonX is a Beijing-headquartered developer of AI-powered digital health ecosystems combining genomic sequencing, wearable data, and machine learning for personalized wellness. The platform analyzes multi-omics data from partnerships with BGI Genomics to deliver health risk scores, disease predictions, and lifestyle recommendations via mobile apps. iCarbonX focuses on chronic disease prevention through continuous monitoring of biomarkers like blood glucose and heart rate variability.

Porter is a Miami-headquartered analytics firm that processes big data for healthcare providers and consumer goods manufacturers. Launched in 2021, it delivers insights on patient outcomes and product performance through proprietary platforms. The company targets pharmaceutical firms and CPG brands seeking operational efficiencies in supply chains and market forecasting.

Welle is a digital health company based in New York providing personalized care plans to mitigate inflammation and chronic disease risks. Its platform uses at-home testing kits for biomarkers like hsCRP and offers nutrition, supplement, and lifestyle recommendations via app-based coaching. Welle targets corporate wellness programs and partners with employers in finance and tech sectors for employee health initiatives.

Hazel Health is a San Francisco-headquartered telehealth provider for K-12 schools across the United States. It connects students to board-certified clinicians via video for treating illnesses like flu, allergies, and mental health concerns. Hazel Health partners with over 300 districts in states including California and Texas, dispensing prescriptions through school dispensaries. Launched in 2019, it conducts 500,000 visits annually with 24/7 coverage.

Iterative Health applies AI to gastrointestinal care through clinical trials and diagnostics. The healthcare technology company accelerates research to advance patient outcomes.

Certara Inc accelerates medicines to patients using biosimulation software and technology to transform traditional drug discovery and development. It provides modeling and simulation, regulatory science, and assessment software and services to help clients reduce clinical trials, accelerate regulatory approval and increase patient access to medicines. The company has its business presence in the Americas which is also it key revenue generating market, EMEA and Asia Pacific region.

Veradigm Inc is a healthcare technology company that drives value through its various combinations of platforms, data, expertise, connectivity, and scale. The company delivers a combination of point-of-care clinical and financial solutions. The Veradigm Network features a dynamic community of solutions and partners providing insights, technology, and data-driven solutions for the healthcare provider, payer, and Life Science markets.

Nutex Health Inc is healthcare services and operations company with 20 hospital facilities in eight states (hospital division), and a primary care-centric, risk-bearing population health management division. The hospital division implements and operates healthcare models, including micro-hospitals, specialty hospitals and hospital outpatient departments (HOPDs). The population health management division owns and operates provider networks such as independent physician associations (IPAs) and offers a cloud-based proprietary technology platform to IPAs that aggregates clinical and claims data across multiple settings, information systems and sources to create a holistic view of patients and providers.